Terms: = Gastric cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
4836 results:
1. treatment of Cachexia in gastric cancer: Exploring the Use of Anti-Inflammatory Natural Products and Their Derivatives.
Loyala JV; Down B; Wong E; Tan B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674936
[TBL] [Abstract] [Full Text] [Related]
2. The Important Role of GPX1 and NF-κB Signaling Pathway in Human gastric cancer: Implications for Cell Proliferation and Invasion.
Jang BI; Jung JY; Koh SA; Lee KH
Cancer Genomics Proteomics; 2024 Apr; 21(3):305-315. PubMed ID: 38670589
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Park MH; Seo JH; Park JH; Seong MK; Park KU; Kim MK; Chang M; Koh SJ; Lee MH; Lim ST; Yoo YB; Oh SY; Kim SH; Ahn KY; Park TH; Ju H; Baek EH; Kim S; Kim N; Lee E; Kim TH
Expert Opin Biol Ther; 2024 Apr; 24(4):305-312. PubMed ID: 38664937
[TBL] [Abstract] [Full Text] [Related]
4. Mitochondrial dysfunction induced by HIF-1α under hypoxia contributes to the development of gastric mucosal lesions.
Xiao Y; Liu X; Xie K; Luo J; Zhang Y; Huang X; Luo J; Tan S
Clin Transl Med; 2024 Apr; 14(4):e1653. PubMed ID: 38616702
[TBL] [Abstract] [Full Text] [Related]
5. Probing the expression and adhesion of glycans involved in Helicobacter pylori infection.
Sijmons D; Collett S; Soliman C; Guy AJ; Scott AM; Durrant LG; Elbourne A; Walduck AK; Ramsland PA
Sci Rep; 2024 Apr; 14(1):8587. PubMed ID: 38615147
[TBL] [Abstract] [Full Text] [Related]
6.
Kalisperati P; Spanou E; Pateras IS; Evangelou K; Thymara I; Korkolopoulou P; Kotsinas A; Vlachoyiannopoulos PG; Tzioufas AG; Kanellopoulos C; Gorgoulis VG; Sougioultzis S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612698
[No Abstract] [Full Text] [Related]
7. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participants.
Wu C; Ke Y; Wan L; Xie X
Cancer Immunol Immunother; 2024 Mar; 73(5):79. PubMed ID: 38554165
[TBL] [Abstract] [Full Text] [Related]
9. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
Zhong Q; Hong W; Xiong L
Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer.
Lin K; Wang Y; Liu F; You T; Liu X; Liu R; Li Z; Zhen C; Zhang Y; Liu X; Cai H
Eur J Med Res; 2024 Mar; 29(1):206. PubMed ID: 38539263
[TBL] [Abstract] [Full Text] [Related]
11. The influence of microwave ablation parameters on the positioning of trocar in different cancerous tissues: a numerical study.
Satish V; Repaka R
Electromagn Biol Med; 2024 Apr; 43(1-2):125-134. PubMed ID: 38533761
[TBL] [Abstract] [Full Text] [Related]
12. Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer.
Zhang K; Xu Y; Chang X; Xu C; Xue W; Ding D; Nie M; Cai H; Xu J; Zhan L; Han J; Cai T; Ju D; Feng L; Zhang X; Yin K
Cancer Immunol Immunother; 2024 Mar; 73(4):75. PubMed ID: 38532108
[TBL] [Abstract] [Full Text] [Related]
13. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract] [Full Text] [Related]
14. Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review.
Peypar MH; Yeganeh AV; Ramazani A; Alizadeh A; Abdorrashidi M; Tohidinia A; Shamlou MM; Heiat M
Helicobacter; 2024; 29(2):e13067. PubMed ID: 38514932
[TBL] [Abstract] [Full Text] [Related]
15. Helicobacter Pylori and gastric cancer: An Update in the Literature.
Toro DH; Bofill-Garcia A; Anzalota-Del Toro M
P R Health Sci J; 2024 Mar; 43(1):9-17. PubMed ID: 38512756
[TBL] [Abstract] [Full Text] [Related]
16. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
17. Valproate modulates the activity of multidrug resistance efflux pumps, as a chemoresistance factor in gastric cancer cells.
Hosseini SA; Mirzaei SA; Kermani S; Yaghoobi H
Mol Biol Rep; 2024 Mar; 51(1):427. PubMed ID: 38498238
[TBL] [Abstract] [Full Text] [Related]
18. Research progress in photodynamic therapy for Helicobacter pylori infection.
Luo Q; Liu C; Zhang A; Zhang D
Helicobacter; 2024; 29(2):e13068. PubMed ID: 38497573
[TBL] [Abstract] [Full Text] [Related]
19. gastric metastasis from breast cancer: five cases and a single-institutional review.
Cheng M; Jia Z; Zhang G; Wang Y; Li S; Yang S; Li C; Geng C
J Int Med Res; 2024 Mar; 52(3):3000605241233988. PubMed ID: 38483129
[TBL] [Abstract] [Full Text] [Related]
20. Nortriptyline hydrochloride, a potential candidate for drug repurposing, inhibits gastric cancer by inducing oxidative stress by triggering the Keap1-Nrf2 pathway.
Zhu C; Lu Y; Wang S; Song J; Ding Y; Wang Y; Dong C; Liu J; Qiu W; Qi W
Sci Rep; 2024 Mar; 14(1):6050. PubMed ID: 38480798
[TBL] [Abstract] [Full Text] [Related]
[Next]